Lazard Asset Management LLC Gilead Sciences, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 444,146 shares of GILD stock, worth $39.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

444,146

Previous 960,982 53.78%

Holding current value

$39.9 Million

Previous $65.9 Million 43.54%

% of portfolio

0.05%

Previous 0.09%

42 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $34.4 Million - $43.4 Million	-516,836 Reduced 53.78%	444,146 $37.2 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $552,625 - $637,772	-8,751 Reduced 0.9%	960,982 $65.9 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.77 Million - $2.15 Million	24,683 Added 2.61%	969,733 $71 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $18.1 Million - $20.5 Million	246,614 Added 35.31%	945,050 $76.6 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $18.4 Million - $20.1 Million	-248,784 Reduced 26.26%	698,436 $52.3 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $19.2 Million - $21.8 Million	-251,974 Reduced 21.01%	947,220 $73 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $27.4 Million - $31.3 Million	354,971 Added 42.05%	1,199,194 $99.5 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $20.2 Million - $29.1 Million	324,758 Added 62.52%	844,223 $72.5 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $7.21 Million - $8.24 Million	121,154 Added 30.42%	519,465 $32 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $11 Million - $12.4 Million	190,766 Added 91.92%	398,311 $24.6 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.4 Million - $1.76 Million	24,215 Added 13.21%	207,545 $12.3 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $11.1 Million - $12.7 Million	171,828 Added 1493.9%	183,330 $13.3 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $470,851 - $507,996	6,956 Added 153.01%	11,502 $803,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $7.19 Million - $7.86 Million	-113,359 Reduced 96.14%	4,546 $312,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.67 Million - $4.19 Million	-61,190 Reduced 34.17%	117,905 $7.62 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $6.3 Million - $7.18 Million	-111,173 Reduced 38.3%	179,095 $10.4 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $8.66 Million - $10.9 Million	-139,430 Reduced 32.45%	290,268 $18.3 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $24.1 Million - $28 Million	333,717 Added 347.69%	429,698 $33.1 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $16.3 Million - $20.8 Million	-259,807 Reduced 73.02%	95,981 $7.18 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $478,356 - $526,176	7,763 Added 2.23%	355,788 $23.1 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $4.25 Million - $4.69 Million	67,995 Added 24.28%	348,025 $22.1 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $4.12 Million - $4.62 Million	66,542 Added 31.17%	280,030 $18.9 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $2.81 Million - $3.14 Million	44,885 Added 26.62%	213,488 $13.9 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $1.77 Million - $2.31 Million	29,178 Added 20.93%	168,603 $10.5 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $60.6 Million - $67.1 Million	-849,980 Reduced 85.91%	139,425 $10.8 Million
Q2 2018 Aug 30, 2019	BUY	$64.88 - $75.68 $617,852 - $720,700	9,523 Added 0.97%	989,405 $70.1 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $410,236 - $478,524	6,323 Added 0.65%	979,882 $69.4 Million
Q1 2018 Aug 28, 2019	SELL	$72.84 - $88.8 $285,241 - $347,740	-3,916 Reduced 0.4%	973,559 $73.4 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $12.1 Million - $14.7 Million	165,955 Added 20.45%	977,475 $73.7 Million
Q4 2017 Aug 28, 2019	SELL	$71.15 - $83.52 $575,176 - $675,175	-8,084 Reduced 0.99%	811,520 $58.1 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $58 Million - $68.1 Million	815,631 Added 20529.35%	819,604 $58.7 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $51.5 Million - $61.1 Million	-714,556 Reduced 99.45%	3,973 $321,000
Q2 2017 Aug 19, 2019	BUY	N/A	713,083 Added 13093.7%	718,529 $50.9 Million
Q1 2017 Aug 13, 2019	SELL	N/A	-2,290 Reduced 29.6%	5,446 $369,000
Q4 2016 Jul 30, 2019	BUY	N/A	918 Added 13.46%	7,736 $553,000
Q3 2016 Aug 07, 2019	SELL	N/A	-1,345 Reduced 16.48%	6,818 $539,000
Q2 2016 Jul 29, 2019	SELL	N/A	-129,350 Reduced 94.06%	8,163 $680,000
Q1 2016 Jul 25, 2019	SELL	N/A	-72,389 Reduced 34.49%	137,513 $12.6 Million
Q4 2015 Jul 24, 2019	BUY	N/A	40,408 Added 23.84%	209,902 $21.2 Million
Q3 2015 Jul 15, 2019	BUY	N/A	35,970 Added 26.94%	169,494 $16.6 Million
Q2 2015 Jul 08, 2019	BUY	N/A	58,547 Added 78.09%	133,524 $15.6 Million
Q4 2014 Aug 29, 2019	BUY	N/A	74,977	74,977 $7.07 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Gilead Sciences, Inc. Transaction History